Duvivier HL, Rothe M, Mangat PK, Garrett-Mayer E, et al. Pembrolizumab in Patients With Tumors With High Tumor Mutational Burden: Results From the Targeted Agent and Profiling Utilization Registry Study. J Clin Oncol 2023;41:5140-5150.
PMID: 37561967